View in EDS

CTAD taskforce: genetic therapies in Alzheimer's disease.

Saved in:
Bibliographic Details
Title: CTAD taskforce: genetic therapies in Alzheimer's disease.
Authors: Jakabek D; University College London, London, UK., Isaacs AM; University College London, London, UK., De Strooper B; UKDRI@ University College London, London, UK and VIB@KULeuven, Belgium., Tuszynski M; University of California San Diego, San Diego, USA., Lane R; IONIS Pharmaceuticals, Carlsbad, USA., Uspenskaya O; Prevail Therapeutics, a wholly-owned subsidiary of Eli Lilly and Company, USA., McDade E; Washington University in St. Louis, Saint Louis, USA., Rafii MS; University of Southern California, Los Angeles, USA., Mummery CJ; University College London, London, UK. Electronic address: cath.mummery@nhs.net.
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Sep; Vol. 12 (8), pp. 100269. Date of Electronic Publication: 2025 Jul 09.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40634156
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CTAD taskforce: genetic therapies in Alzheimer's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jakabek+D%22">Jakabek D</searchLink>; University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Isaacs+AM%22">Isaacs AM</searchLink>; University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22De+Strooper+B%22">De Strooper B</searchLink>; UKDRI@ University College London, London, UK and VIB@KULeuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Tuszynski+M%22">Tuszynski M</searchLink>; University of California San Diego, San Diego, USA.<br /><searchLink fieldCode="AU" term="%22Lane+R%22">Lane R</searchLink>; IONIS Pharmaceuticals, Carlsbad, USA.<br /><searchLink fieldCode="AU" term="%22Uspenskaya+O%22">Uspenskaya O</searchLink>; Prevail Therapeutics, a wholly-owned subsidiary of Eli Lilly and Company, USA.<br /><searchLink fieldCode="AU" term="%22McDade+E%22">McDade E</searchLink>; Washington University in St. Louis, Saint Louis, USA.<br /><searchLink fieldCode="AU" term="%22Rafii+MS%22">Rafii MS</searchLink>; University of Southern California, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Mummery+CJ%22">Mummery CJ</searchLink>; University College London, London, UK. Electronic address: cath.mummery@nhs.net.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101638820%22">The journal of prevention of Alzheimer's disease</searchLink> [J Prev Alzheimers Dis] 2025 Sep; Vol. 12 (8), pp. 100269. <i>Date of Electronic Publication: </i>2025 Jul 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101638820 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2426-0266 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222745807%22">22745807 </searchLink><i>NLM ISO Abbreviation: </i>J Prev Alzheimers Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40634156
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.tjpad.2025.100269
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100269
    Titles:
      – TitleFull: CTAD taskforce: genetic therapies in Alzheimer's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jakabek D
      – PersonEntity:
          Name:
            NameFull: Isaacs AM
      – PersonEntity:
          Name:
            NameFull: De Strooper B
      – PersonEntity:
          Name:
            NameFull: Tuszynski M
      – PersonEntity:
          Name:
            NameFull: Lane R
      – PersonEntity:
          Name:
            NameFull: Uspenskaya O
      – PersonEntity:
          Name:
            NameFull: McDade E
      – PersonEntity:
          Name:
            NameFull: Rafii MS
      – PersonEntity:
          Name:
            NameFull: Mummery CJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2426-0266
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: The journal of prevention of Alzheimer's disease
              Type: main
ResultId 1